Product Information
Drug-resistant Plasmodium falciparum malaria is a major contributor to the increasing malaria related morbidity and mortality. Combination of conventional antimalarial drugs with artemisinin derivatives is a treatment option for resistant P. falciparum. Amodiaquine-artesunate is a potential combination for inhibiting intensification of drug resistance and for decreasing malaria transmission levels. The combination shows improved treatment efficacy.
Artesunate is an antimalarial agent. It is a water-soluble hemisuccinate derivative of artemisinin. Artemisinin is a sesquiterpene lactone isolated from Artemisia annua, a herb that has traditionally been used in China for the treatment of malaria. Artesunate and its active metabolite dihydroartemisinin are potent blood schizonticides, active against the ring stage of the parasite. Artesunate is ideal for the treatment of severe malaria, including cerebral malaria. It is also active against chloroquine and mefloquine resistant strains of P. falciparum.
Product Packaging
The dosages available for this product are
- Artesunate 50mg + Amodiaquine 150mg Tablets (12+12 tablets/blister, 1 blister/box)
- Artesunate 50mg + Amodiaquine 153mg Tablets (12+12 tablets/blister, 1 blister/box)
- Artesunate 50mg + Amodiaquine 200mg Tablets (12+12 tablets/blister, 1 blister/box)
- Artesunate 100mg + Amodiaquine 300mg Tablets (6+6 tablets/blister, 1 blister/box)
- Artesunate 200mg + Amodiaquine 600mg Tablets (3+3 tablets/blister, 1 blister/box)
The recommended packaging for this product is above. This product can also be packaged according the customer's requirements.
